2m 2m 2m 2m 2m 2m 2m
CORB PHRM HLDGS (CRBP)
NASDAQ
$9.07+$0.10 (+1.11%)
Price as of Aug 03, 2026 6:45 PM EDT- $166.2MMarket Cap
- -3.65%1-Year Change
- BiotechnologyIndustry
CORB PHRM HLDGS (CRBP)
$9.07+$0.10 (+1.11%)
CRBP | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $8.97 | ||
Change | -$0.08 (-0.88%) | ||
Open | $9.06 | ||
High | $9.16 | ||
Low | $8.62 | ||
Previous Close | $9.05 | ||
Volume | 348,854 | ||
30-Day Average Volume | 298,125 | ||
1-Week Change | -2.18% | ||
1-Month Change | -4.37% | ||
1-Year Change | -3.65% | ||
3-Year Change | 24.58% | ||
5-Year Change | -78.18% | ||
Fundamentals | |||
Shares Outstanding | 18.5M | ||
Total Assets | $144.5M | ||
Market Cap | $166.2M | ||
Enterprise Value | $140.5M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$23.0M | ||
Free Cash Flow | -$25.6M | ||
EBIT | -$23.0M | ||
EBITDA | -$22.9M | ||
Net Working Capital | $125.4M | ||
EPS | -$1.23 | ||
Enterprise Value/EBITDA | -6 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 1 | ||
P/E | -7 | ||
PEG | -5 | ||
Price/Free Cash Flow | -6 | ||
Price/Operating Cash Flow | -6 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 30 | ||
Last Split Date | 02/14/2023 | ||
Earnings & Revenue